As part of our mission to prevent and control cancer, we aim not only to seek out and support crucial research, but also to enable those suffering with these disease to live their best lives. During the ongoing lockdown early in the new financial year we continued to keep treatment accessible and patients connected through the rapid introduction of our programs, and continued to see out global partnership, despite lockdowns. Believe in treating the individual, and not the condition, we launched programs that see worldclass and innovative treatment accessible to those who need it most, despite their geographic or financial situation.